Cleared Traditional

K223094 - EnSite™ X EP System TactiFlex™ Ablation Catheter, Sensor Enabled™, Software Upgrade (FDA 510(k) Clearance)

Also includes:
EnSite™ X EP System TactiFlex™ Ablation Catheter, Sensor Enabled™, Software License
Dec 2022
Decision
88d
Days
Class 2
Risk

K223094 is an FDA 510(k) clearance for the EnSite™ X EP System TactiFlex™ Ablation Catheter, Sensor Enabled™, Software Upgrade. This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).

Submitted by Abbott Medical (St. Paul, US). The FDA issued a Cleared decision on December 27, 2022, 88 days after receiving the submission on September 30, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.

Submission Details

510(k) Number K223094 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2022
Decision Date December 27, 2022
Days to Decision 88 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQK — Computer, Diagnostic, Programmable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1425

Similar Devices — DQK Computer, Diagnostic, Programmable

All 44
HemoSphere Nano Monitor (HSNANO1)
K253186 · Edwards Lifesciences, LLC · Feb 2026
CARTO™ 3 EP Navigation System V8.4
K252972 · Biosense Webster, Inc. · Feb 2026
Holter ECG and ABP system (HolterABP)
K251591 · Edan Instruments, Inc. · Feb 2026
CARTO™ 3 EP Navigation System V9.0 with PIU Plus
K254085 · Biosense Webster, Inc. · Jan 2026
LumiGuide Equipment R2.1
K252645 · Philips Medical Systems Nederland B.V. · Oct 2025
EnSite™ X EP System
K252013 · Abbott Medical · Sep 2025